GluBio Therapeutics Inc Email Formats

Biotechnology Research • China • 11-20 Employees

GluBio Therapeutics Inc Email Formats

GluBio Therapeutics Inc uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@glubiotx.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@glubiotx.com	100%

Key Contact at GluBio Therapeutics Inc

Hannah Zhang

Senior Vice President, Translational Medicine & Early Clinical Development

Company overview

Headquarters	China
Website	glubiotx.com
NAICS	541714
Founded	2021
Employees	11-20
Socials

About GluBio Therapeutics Inc

GluBio Therapeutics is a pioneering TPD company dedicated to developing targeted protein degraders for human diseases with unmet medical needs. Founded by seasoned drug developers with deep knowledge and expertise in TPD drug discovery, the company has established a proprietary TPD discovery platform and robust screening capability. GluBio is advancing a diverse pipeline of highly selective small-molecule degraders across multiple therapeutic areas including oncology and immunology. The company has research operations in both San Diego, CA, USA and Shanghai, China.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Vice President

Funding Data

Explore GluBio Therapeutics Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-09-01	4	$22,000,000

Funding Insights

$22,000,000

Total funding amount

$22,000,000

Most recent funding amount

Number of funding rounds

GluBio Therapeutics Inc Tech Stack

Discover the technologies and tools that power GluBio Therapeutics Inc's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery

JavaScript libraries

CivicTheme

UI frameworks

HTTP/3

Miscellaneous

Popper

Miscellaneous

Microsoft 365

Frequently asked questions

GluBio Therapeutics Inc is located in CN.

GluBio Therapeutics Inc was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

GluBio Therapeutics Inc has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

GluBio Therapeutics Inc has raised a total of $22,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at GluBio Therapeutics Inc

Hannah Zhang

Senior Vice President, Translational Medicine & Early Clinical Development

4.8

40,000 users